Independent and combined effects of astaxanthin and omega-3 on behavioral deficits and molecular changes in a prenatal valproic acid model of autism in rats

References

• Faras H, al Ateeqi N, Tidmarsh L. Autism spectrum disorders. Ann Saudi Med. 2010;30(4):295–300. doi:10.4103/0256-4947.65261.
   PubMed Web of Science ®Google Scholar
• Rapin I, Tuchman RF. Autism: definition, neurobiology, screening, diagnosis. Pediatr Clin N Am. 2008;55(5):1129–46. doi:10.1016/J.PCL.2008.07.005.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association Publishing; 2022. doi:10.1176/appi.books.9780890425787.
   Google Scholar
• Centers for Disease Control and Prevention. (n.d.). [accessed 2023 Jan 2]. Available from: https://www.cdc.gov/.
   Google Scholar
• World Health Organization (WHO). (n.d.). [accessed 2023 Jan 2]. Available from: https://www.who.int/.
   Google Scholar
• Eve M, Gandawijaya J, Yang L, Oguro-Ando A. Neuronal cell adhesion molecules may mediate neuroinflammation in autism spectrum disorder. Front Psychiatry. 2022;13:842755. doi:10.3389/FPSYT.2022.842755.
   PubMed Web of Science ®Google Scholar
• Guerra DJ. The molecular genetics of autism spectrum disorders: genomic mechanisms, neuroimmunopathology, and clinical implications. Autism Res Treat. 2011;2011:398636), doi:10.1155/2011/398636.
   PubMedGoogle Scholar
• Zawadska A, Magdalena C, Adamczyk A. The role of maternal immune activation in the pathogenesis of autism: a review of the evidence, proposed mechanisms and implications for treatment. Int J Mol Sci. 2021;22(21):11516. doi:10.3390/ijms222111516.
   PubMed Web of Science ®Google Scholar
• Lamy M, Erickson CA. Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders. Curr Probl Pediatr Adolesc Health Care. 2018;48(10):250–64. doi:10.1016/J.CPPEDS.2018.08.015.
   PubMed Web of Science ®Google Scholar
• Marcus RN, Owen R, Manos G, Mankoski R, Kamen L, McQuade RD, et al. Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study. J Clin Psychiatry. 2011;72(9):1270–6. doi:10.4088/JCP.09M05933.
   PubMed Web of Science ®Google Scholar
• Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, et al. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics. 2004;114(5):634–41. doi:10.1542/PEDS.2003-0264-F.
   PubMed Web of Science ®Google Scholar
• Naber D, Lambert M. The CATIE and CUtLASS studies in schizophrenia: results and implications for clinicians. CNS Drugs. 2009;23(8):649–59. doi:10.2165/00023210-200923080-00002/METRICS.
   PubMed Web of Science ®Google Scholar
• Ghodke-Puranik Y, Thorn CF, Lamba JK, Leeder JS, Song W, Birnbaum AK, et al. Valproic acid pathway: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics. 2013;23(4):236–41. doi:10.1097/FPC.0B013E32835EA0B2.
   PubMed Web of Science ®Google Scholar
• Patterson PH. Modeling autistic features in animals. Pediatr Res. 2011;69(8):34–40. doi:10.1203/pdr.0b013e318212b80f.
   PubMedGoogle Scholar
• Bambini-Junior V, Zanatta G, della Flora Nunes G, Mueller de Melo G, Michels M, Fontes-Dutra M, et al. Resveratrol prevents social deficits in animal model of autism induced by valproic acid. Neurosci Lett. 2014;583:176–81. doi:10.1016/J.NEULET.2014.09.039.
   PubMed Web of Science ®Google Scholar
• Cohen OS, Varlinskaya EI, Wilson CA, Glatt SJ, Mooney SM. Acute prenatal exposure to a moderate dose of valproic acid increases social behavior and alters gene expression in rats. Int J Dev Neurosci. 2013;31(8):740–50. doi:10.1016/J.IJDEVNEU.2013.09.002.
   PubMed Web of Science ®Google Scholar
• Martin HGS, Manzoni OJ. Late onset deficits in synaptic plasticity in the valproic acid rat model of autism. Front Cell Neurosci. 2014;8:23. doi:10.3389/fncel.2014.00023.
   PubMed Web of Science ®Google Scholar
• Kataoka S, Takuma K, Hara Y, Maeda Y, Ago Y, Matsuda T. Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. Int J Neuropsuchopharmacolog. 2013;16(1):91–103. doi:10.1017/S1461145711001714.
   PubMed Web of Science ®Google Scholar
• Gzielo K, Potasiewicz A, Hołuj M, Litwa E, Popik P, Nikiforuk A. Valproic acid exposure impairs ultrasonic communication in infant, adolescent and adult rats. Eur Neuropsychopharmacol. 2020;41:52–62. doi:10.1016/j.euroneuro.2020.09.006.
   PubMed Web of Science ®Google Scholar
• Schneider T, Roman A, Basta-Kaim A, Kubera M, Budziszewska B, Schneider K, Przewłocki R. Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology. 2008;33(6):728–40. doi:10.1016/j.psyneuen.2008.02.011.
   PubMed Web of Science ®Google Scholar
• Dufour-Rainfray D, Vourc’h P, le Guisquet AM, Garreau L, Ternant D, Bodard S, et al. Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism. Neurosci Lett. 2010;470(1):55–9. doi:10.1016/J.NEULET.2009.12.054.
   PubMed Web of Science ®Google Scholar
• Narita N, Kato M, Tazoe M, Miyazaki K, Narita M, Okado N. Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid–exposed rat: putative animal models for autism. Pediatr Res. 2002;52(4):576–9. doi:10.1203/00006450-200210000-00018.
   PubMed Web of Science ®Google Scholar
• Kolozsi E, Mackenzie RN, Roullet FI, deCatanzaro D, Foster JA. Prenatal exposure to valproic acid leads to reduced expression of synaptic adhesion molecule neuroligin 3 in mice. Neuroscience. 2009;163(4):1201–10. doi:10.1016/j.neuroscience.2009.07.021.
   PubMed Web of Science ®Google Scholar
• Bringas ME, Carvajal-Flores FN, Lopez-Ramirez TA, Atzori M, Flores G. Rearrangement of the dendritic morphology in limbic regions and altered exploratory behavior in a rat model of autism spectrum disorder. Neuroscience. 2013;241:170–87. doi:10.1016/j.neuroscience.2013.03.030.
   PubMed Web of Science ®Google Scholar
• Rinaldi T, Silberberg G, Markram H. Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid. Cereb Cortex. 2008;18(4):763–70. doi:10.1093/cercor/bhm117.
   PubMed Web of Science ®Google Scholar
• Rinaldi T, Perrodin C, Markram H. Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism. Front Neural Circuits. 2008;2:4. doi:10.3389/neuro.04.004.2008.
   PubMed Web of Science ®Google Scholar
• Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, et al. Elevated immune response in the brain of autistic patients. J Neuroimmunol. 2009;207(1–2):111–6. doi:10.1016/J.JNEUROIM.2008.12.002.
   PubMed Web of Science ®Google Scholar
• Kim UJ, Hong N, Ahn JC. Photobiomodulation attenuated cognitive dysfunction and neuroinflammation in a prenatal valproic acid-induced autism spectrum disorder mouse model. Int J Mol Sci. 2022;23(24):16099. doi:10.3390/ijms232416099.
   PubMed Web of Science ®Google Scholar
• Codagnone MG, Podesta MF, Uccelli NA, Reines A. Differential local connectivity and neuroinflammation profiles in the medial prefrontal cortex and hippocampus in the valproic acid rat model of autism. Dev Neurosci. 2015;37(3):215–31. doi:10.1159/000375489.
   PubMed Web of Science ®Google Scholar
• Baron-Cohen S, Ring H, Moriarty J, Schmitz B, Costa D, Ell P. Recognition of mental state terms. Clinical findings in children with autism and a functional neuroimaging study of normal adults. Br J Psychiatry. 1994;165(5):640–9. doi:10.1192/bjp.165.5.640.
   PubMed Web of Science ®Google Scholar
• Baron-Cohen S, Ring H, Wheelwright S, Bullmore ET, Brammer MJ, Simmons A, Williams SC. Social intelligence in the normal and autistic brain: an fMRI study. Eur J Neurosci. 1999;11(6):1891–8. doi:10.1046/j.1460-9568.1999.00621.x.
   PubMed Web of Science ®Google Scholar
• Banker S, Gu X, Schiller D, Foss-Feig J. Hippocampal contributions to social and cognitive deficits in autism spectrum disorder. Trends Neurosci. 2021;44(10):793–807. doi:10.1016/j.tins.2021.08.005.
   PubMed Web of Science ®Google Scholar
• Bourre JM, Dumont O, Piciotti M, Clément M, Chaudière J, Bonneil M, et al. Essentiality of omega 3 fatty acids for brain structure and function. World Rev Nutr Diet. 1991;66:103–17. doi:10.1159/000419283.
   PubMedGoogle Scholar
• Haas HS, Schauenstein K. Immunity, hormones, and the brain. Allergy. 2001;56(6):470–7. doi:10.1034/J.1398-9995.2001.056006470.X.
   PubMed Web of Science ®Google Scholar
• Innis SM. Omega-3 fatty acid biochemistry: perspectives from human nutrition. Mil Med. 2014;179(suppl_11):82–7. doi:10.7205/MILMED-D-14-00147.
   PubMed Web of Science ®Google Scholar
• Bang HO, Dyerberg J, Nielsen AB. Plasma lipid and lipoprotein pattern in Greenlandic West-Coast Eskimos. Nutr Rev. 1986;44(4):143–6. doi:10.1111/J.1753-4887.1986.TB07607.X.
   PubMed Web of Science ®Google Scholar
• Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet. 1978;312(8081):117–9. doi:10.1016/S0140-6736(78)91505-2.
   Google Scholar
• Raj P, Singh M, Rawat JK, Gautam S, Saraf SA, Kaithwas G. Effect of enteral administration of α-linolenic acid and linoleic acid against methotrexate induced intestinal toxicity in albino rats. RSC Adv. 2014;4(104):60397–403. doi:10.1039/C4RA10213D.
   Web of Science ®Google Scholar
• Kohli P, Levy BD. Resolvins and protectins: mediating solutions to inflammation. Br J Pharmacol. 2009;158(4):960–71. doi:10.1111/J.1476-5381.2009.00290.X.
   PubMed Web of Science ®Google Scholar
• Spite M, Clària J, Serhan CN. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab. 2014;19(1):21–36. doi:10.1016/J.CMET.2013.10.006.
   PubMed Web of Science ®Google Scholar
• Kern JK, Jones AM. Evidence of toxicity, oxidative stress, and neuronal insult in autism. Journal of Toxicology and Environmental Health, Part B. 2007;9(6):485–99. doi:10.1080/10937400600882079.
   Web of Science ®Google Scholar
• Sajdel-Sulkowska EM, Xu M, Koibuchi N. Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism. Cerebellum. 2009;8(3):366–72. doi:10.1007/S12311-009-0105-9/FIGURES/3.
   PubMed Web of Science ®Google Scholar
• Bahbah EI, Ghozy S, Attia MS, Negida A, Emran Tb, Mitra S, et al. Molecular mechanisms of astaxanthin as a potential neurotherapeutic agent. Mar Drugs. 2021;19(4):201. doi:10.3390/MD19040201.
   PubMed Web of Science ®Google Scholar
• Al-Amin MM, Rahman MM, Khan FR, Zaman F, Mahmud Reza H. Astaxanthin improves behavioral disorder and oxidative stress in prenatal valproic acid-induced mice model of autism. Behav Brain Res. 2015;286:112–21. doi:10.1016/J.BBR.2015.02.041.
   PubMed Web of Science ®Google Scholar
• Singh R, Kisku A, Kungumaraj H, Nagaraj V, Pal A, Kumar S, Sulakhiya K. Autism spectrum disorders: a recent update on targeting inflammatory pathways with natural anti-inflammatory agents. Biomedicines. 2023;11(1):115. doi:10.3390/biomedicines11010115.
   PubMed Web of Science ®Google Scholar
• Pangrazzi L, Balasco L, Bozzi Y. Natural antioxidants: a novel therapeutic approach to autism spectrum disorders? Antioxidants. 2020;9((12):1186. doi:10.3390/antiox9121186.
   Web of Science ®Google Scholar
• Veselinović A, Petrović S, Žikić V, Subotić M, Jakovljević V, Jeremić N, Vučić V. Neuroinflammation in autism and supplementation based on omega-3 polyunsaturated fatty acids: a narrative review. Medicina (B Aires). 2021;57(9):893. doi:10.3390/MEDICINA57090893.
   Google Scholar
• Alfawaz H, Al-Onazi M, Bukhari SI, Binobead M, Othman N, Algahtani N, et al. The independent and combined effects of omega-3 and vitamin B12 in ameliorating propionic acid induced biochemical features in juvenile rats as rodent model of autism. J Mol Neurosci. 2018;66(3):403–13. doi:10.1007/s12031-018-1186-z.
   PubMed Web of Science ®Google Scholar
• Iwata K. Characterization of an animal model of autism and social interaction. Methods Mol Biol. 2019;1916:149–55. doi:10.1007/978-1-4939-8994-2_14.
   PubMedGoogle Scholar
• Yang M, Silverman JL, Crawley JN. Automated three-chambered social approach task for mice. Curr Protoc Neurosci. 2011;doi:10.1002/0471142301.ns0826s56.
   PubMedGoogle Scholar
• Bevins RA, Besheer J. Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study ‘recognition memory’. Nat Protoc. 2006;1(3):1306–11. doi:10.1038/nprot.2006.205.
   PubMed Web of Science ®Google Scholar
• Swerdlow NR. Prepulse inhibition of startle in humans and laboratory models. Encyclopedia of Neuroscience. Academic Press; . 2009. p. 947–55. doi:10.1016/B978-008045046-9.01938-0.
   Google Scholar
• Mansbach RS, Geyer MA, Braff DL. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berl). 1988;94(4):507–14. doi:10.1007/BF00212846.
   PubMed Web of Science ®Google Scholar
• Courchesne E, Mouton PR, Calhoun ME, Semendeferi K, Ahrens-Barbeau C, Hallet MJ, et al. Neuron number and size in prefrontal cortex of children with autism. JAMA. 2011;306(18):2001–10. doi:10.1001/jama.2011.1638.
   PubMed Web of Science ®Google Scholar
• Stoner R, Chow ML, Boyle MP, Sunkin SM, Mouton PR, Roy S, et al. Patches of disorganization in the neocortex of children with autism. N Engl J Med. 2014;370(13):1209–19. doi:10.1056/NEJMoa1307491.
   PubMed Web of Science ®Google Scholar
• Hashemi E, Ariza J, Rogers H, Noctor SC, Martínez-Cerdeño V. The number of parvalbumin-expressing interneurons is decreased in the medial prefrontal cortex in autism. Cereb Cortex. 2017;27(3):1931–43. doi:10.1093/cercor/bhw021.
   PubMed Web of Science ®Google Scholar
• Azmitia EC, Singh JS, Hou XP, Wegiel J. Dystrophic serotonin axons in postmortem brains from young autism patients. Anat Rec. 2011;294(10):1653–62. doi:10.1002/ar.21243.
   Google Scholar
• Sheikh AM, Li X, Wen G, Tauqeer Z, Brown WT, Malik M. Cathepsin D and apoptosis related proteins are elevated in the brain of autistic subjects. Neuroscience. 2010;165(2):363–70. doi:10.1016/j.neuroscience.2009.10.035.
   PubMed Web of Science ®Google Scholar
• Takumi T, Tamada K, Hatanaka F, Nakai N, Bolton PF. Behavioral neuroscience of autism. Neurosci Biobehav Rev. 2020;110:60–76. doi:10.1016/J.NEUBIOREV.2019.04.012.
   PubMed Web of Science ®Google Scholar
• Du L, Zhao G, Duan Z, Li F. Behavioral improvements in a valproic acid rat model of autism following vitamin D supplementation. Psychiatry Res. 2017;253:28–32. doi:10.1016/J.PSYCHRES.2017.03.003.
   PubMed Web of Science ®Google Scholar
• Chaliha D, Albrecht M, Vaccarezza M, Takechi R, Lam V, Al-Salami H, Mamo J. A systematic review of the valproic-acid-induced rodent model of autism. Dev Neurosci. 2020;42(1):12–48. doi:10.1159/000509109.
   PubMed Web of Science ®Google Scholar
• Doaei S, Bourbour F, Teymoori Z, Jafari F, Kalantari N, Torki SA, et al. The effect of omega-3 fatty acids supplementation on social and behavioral disorders of children with autism: a randomized clinical trial. Pediatr Endocrinol Diabetes Metab. 2021;27(1):12–8. doi:10.5114/pedm.2020.101806.
   PubMedGoogle Scholar
• Silverman JL, Oliver CF, Karras MN, Gastrell PT, Crawley JN. AMPAKINE enhancement of social interaction in the BTBR mouse model of autism. Neuropharmacology. 2013;64:268–82. doi:10.1016/J.NEUROPHARM.2012.07.013.
   PubMed Web of Science ®Google Scholar
• Bhattacharya A, Kaphzan H, Alvarez-Dieppa AC, Murphy JP, Pierre P, Klann E. Genetic removal of p70 S6 Kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice. Neuron. 2012;76(2):325–37. doi:10.1016/j.neuron.2012.07.022.
   PubMed Web of Science ®Google Scholar
• Taksima T, Chonpathompikunlert P, Sroyraya M, Hutamekalin P, Limpawattana M, Klaypradit W. Effects of astaxanthin from shrimp shell on oxidative stress and behavior in animal model of Alzheimer’s disease. Mar Drugs. 2019;17(11):628. doi:10.3390/MD17110628.
   PubMed Web of Science ®Google Scholar
• Rahman SO, Panda BP, Parvez S, Kaundal M, Hussain S, Akhtar M, Najmi AK. Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer’s disease. Biomed Pharmacother. 2019;110:47–58. doi:10.1016/J.BIOPHA.2018.11.043.
   PubMed Web of Science ®Google Scholar
• de Andrade AM, Fernandes M da C, de Fraga LS, Porawski M, Giovenardi M, Guedes RP. Omega-3 fatty acids revert high-fat diet-induced neuroinflammation but not recognition memory impairment in rats. Metab Brain Dis. 2017;32(6):1871–81. doi:10.1007/S11011-017-0080-7/FIGURES/4.
   PubMed Web of Science ®Google Scholar
• Abd Allah E, Gomaa A, Sayed M. The effect of omega-3 on cognition in hypothyroid adult male rats. Acta Physiol Hung. 2014;101(3):362–76. doi:10.1556/APHYSIOL.101.2014.3.11.
   PubMedGoogle Scholar
• Gao J, Wang X, Sun H, Cao Y, Liang S, Wang H, et al. Neuroprotective effects of docosahexaenoic acid on hippocampal cell death and learning and memory impairments in a valproic acid-induced rat autism model. Int J Dev Neurosci. 2016;49:67–78. doi:10.1016/j.ijdevneu.2015.11.006.
   PubMed Web of Science ®Google Scholar
• Schneider T, Przewłocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology. 2004;30(1):80–9. doi:10.1038/sj.npp.1300518.
   Web of Science ®Google Scholar
• Zugno AI, Chipindo HL, Volpato AM, Budni J, Steckert A, de Oliveira MB, et al. Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia. Neuroscience. 2014;259:223–31. doi:10.1016/J.NEUROSCIENCE.2013.11.049.
   PubMed Web of Science ®Google Scholar
• Casquero-Veiga M, Romero-Miguel D, MacDowell KS, Torres-Sanchez S, Garcia-Partida JA, Lamanna-Rama N, et al. Omega-3 fatty acids during adolescence prevent schizophrenia-related behavioural deficits: neurophysiological evidences from the prenatal viral infection with Poly I:C. Eur Neuropsychopharmacol. 2021;46:14–27. doi:10.1016/J.EURONEURO.2021.02.001.
   PubMed Web of Science ®Google Scholar
• Davis JLB, O’connor M, Erlbacher H, Schlichte SL, Stevens HE. The impact of maternal antioxidants on prenatal stress effects on offspring neurobiology and behavior. Yale J Biol Med. 2022;95(1):87.
   PubMed Web of Science ®Google Scholar
• Matta SM, Hill-Yardin EL, Crack PJ. The influence of neuroinflammation in autism spectrum disorder. Brain Behav Immun. 2019;79:75–90. doi:10.1016/J.BBI.2019.04.037.
   PubMed Web of Science ®Google Scholar
• Cristiano C, Volpicelli F, Crispino M, Lacivita E, Russo R, Leopoldo M, et al. Behavioral, anti-inflammatory, and neuroprotective effects of a novel FPR2 agonist in two mouse models of autism. Pharmaceuticals. 2022;15(2):161. doi:10.3390/PH15020161/S1.
   Web of Science ®Google Scholar
• Elnahas EM, Abuelezz SA, Mohamad MI, Nabil MM, Abdelraouf SM, Bahaa N, et al. Validation of prenatal versus postnatal valproic acid rat models of autism: a behavioral and neurobiological study. Prog Neuro-Psychopharmacol Biol Psychiatr. 2021;108:110185. doi:10.1016/J.PNPBP.2020.110185.
   PubMed Web of Science ®Google Scholar
• Pardo CA, Charles GE. The neurobiology of autism. Brain Pathol. 2007;17(4):434–47. doi:10.1111/j.1750-3639.2007.00102.x.
   PubMed Web of Science ®Google Scholar
• Mazahery H, Stonehouse W, Delshad M, Kruger MC, Conlon CA, Beck KL, et al. Relationship between long chain n-3 polyunsaturated fatty acids and autism spectrum disorder: systematic review and meta-analysis of case-control and randomised controlled trials. Nutrients. 2017;9(2):155. doi:10.3390/nu9020155.
   PubMed Web of Science ®Google Scholar
• Amminger GP, Berger GE, Schäfer MR, Klier C, Friedrich MH, Feucht M. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry. 2007;61(4):551–3. doi:10.1016/j.biopsych.2006.05.007.
   PubMed Web of Science ®Google Scholar
• Bent S, Hendren RL, Zandi T, Law K, Choi JE, Widjaja F, et al. Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism. J Acad Child Adolesc Psychiatry. 2014;53(6):658–66. doi:10.1016/j.jaac.2014.01.018.
   PubMed Web of Science ®Google Scholar
• Voigt RG, Mellon MW, Katusic SK, Weaver AL, Matern D, Mellon B, et al. Dietary docosahexaenoic acid supplementation in children with autism. J Pediatr Gastroenterol Nutr. 2014;58(6):715–22. doi:10.1097/MPG.0000000000000260.
   PubMed Web of Science ®Google Scholar
• Kim RE, Shin CY, Han SH, Kwon KJ. Astaxanthin suppresses PM2.5-induced neuroinflammation by regulating Akt phosphorylation in BV-2 microglial cells. Int J Mol Sci. 2020;21(19):7227. doi:10.3390/IJMS21197227.
   PubMed Web of Science ®Google Scholar
• Wang S, Qi X. The putative role of astaxanthin in neuroinflammation modulation: mechanisms and therapeutic potential. Front Pharmacol. 2022;13:2458. doi:10.3389/FPHAR.2022.916653/BIBTEX.
   Web of Science ®Google Scholar
• Chang MX, Xiong F, Pak S, Liang Ooi S. Astaxanthin and its effects in inflammatory responses and inflammation-associated diseases: recent advances and future directions. Molecules. 2020;25(22):5342. doi:10.3390/MOLECULES25225342.
   PubMed Web of Science ®Google Scholar
• Naguib YM. Antioxidant activities of astaxanthin and related carotenoids. J Agric Food Chem. 2000;48(4):1150–4. doi:10.1021/jf991106k.
   PubMed Web of Science ®Google Scholar
• Barros MP, Poppe SC, Bondan EF. Neuroprotective properties of the marine carotenoid astaxanthin and omega-3 fatty acids, and perspectives for the natural combination of both in Krill oil. Nutrients. 2014;6(3):1293–317. doi:10.3390/nu6031293.
   PubMed Web of Science ®Google Scholar
• Shen H, Kuo C, Chou J, Delvolve A, Jackson SN, Post J, et al. Astaxanthin reduces ischemic brain injury in adult rats. FASEB J. 2009;23(6):1958–68. doi:10.1096/fj.08-123281.
   PubMed Web of Science ®Google Scholar
• Wu W, Wang X, Xiang Q, Meng X, Peng Y, Du N, et al. Astaxanthin alleviates brain aging in rats by attenuating oxidative stress and increasing BDNF levels. Food Funct 2014;5(1):158–66. doi:10.1039/c3fo60400d.
   PubMed Web of Science ®Google Scholar
• Madore C, Leyrolle Q, Lacabanne C, Benmamar-Badel A, Joffre C, Nadjar A, Laye S. Neuroinflammation in autism: plausible role of maternal inflammation, dietary omega 3, and microbiota. Neural Plast. 2016: 3597209. doi:10.1155/2016/3597209.
   PubMed Web of Science ®Google Scholar
• Kaliannan K, Wang B, Li X, Kim K, Kang JX. A host-microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia. Sci Rep. 2015;5:11276. doi:10.1038/srep11276.
   PubMed Web of Science ®Google Scholar